SOURCE: BioLargo, Inc.

BioLargo, Inc.

February 19, 2015 14:55 ET

BioLargo's Isan System Showcased at World AG Expo for Its Commercial Debut in USA

SANTA ANA, CA--(Marketwired - Feb 19, 2015) -  BioLargo, Inc. (OTCQB: BLGO) announced today that its licensing partner Clarion Water introduced the new and improved Isan System at the world's largest agricultural trade show, the World AG Expo, as part of its commercial launch into the U.S. market. The Isan system is an innovative, environmentally friendly, fully automated, cost effective disinfection solution for agriculture, horticulture, waste-water, manufacturing and industrial applications.

Since licensing the technology from BioLargo last August, Clarion has completed a comprehensive technical and engineering update to the Isan System, featuring a new automated touch screen user interface, enhanced security, enhanced control features for increased monitoring and sensing, and adding automated functionality providing users unmatched flexibility, reliability and control over this state-of-the-art disinfectant delivery system, and begun commercial trials. 

Already referred to as one of the most important technical advancements in food safety in the past 20 years, the Isan System won a "top 50 water company award" by the Artemis Project in 2010 and a DuPont Innovation Award for its excellence in science and innovation in 2004. Early versions of system have been widely used, trialed, tested and validated in multiple commercial markets over the past 10 years in the USA, Australia, New Zealand and Japan. 

Tom Bercaw, President and founder of Clarion Water, commented, "We are excited about the significant commercial opportunities for the Isan technology in the United States. With our most recent technical and engineering improvements complete, we have shifted our focus to trials, sales and marketing. The World AG Expo allowed us to connect face-to-face with a host of potential clients and confirm their interest and need for a functional system that can precisely and safely deliver and leverage the power of all natural iodine. The response from the marketplace is very positive and welcoming."

BioLargo president Dennis Calvert commented, "These recent developments confirm our confidence in Clarion's ability to deliver our innovative technology to the commercial market. Clarion brings marketing savvy, skilled engineering, manufacturing expertise, an unsurpassed commitment to service, and a long track record of success."

About Clarion Water

Clarion Water is an operating division of InsulTech Manufacturing, LLC (, which has over 20 years of commercial success around the globe representing hundreds of millions in sales of technical products to Fortune 100 companies.

About BioLargo, Inc.

BioLargo, Inc. (OTCQB: BLGO) makes life better by delivering technology-based products that help solve some of the world's most important problems that threaten water, food, agriculture, healthcare and energy. More information can be found about the company and its subsidiaries at The subsidiary BioLargo Water, Inc. ( showcases the Advanced Oxidation Systems, including its AOS Filter, a product in development specifically designed to eliminate common, troublesome, and dangerous (toxic) contaminants in water in a fraction of the time and cost of current technologies, It is the winner of the Technology Star award by New Technology Magazine for its breakthrough innovation for the oil industry. BioLargo also owns a 50% interest in the Isan System, which was honored with a "Top 50 Water Company for the 21st Century" award by the Artemis Project. The subsidiary Odor-No-More Inc., features award-winning products serving the pet, equine, and consumer markets, including the Nature's Best Solution® and Deodorall® brands ( The subsidiary, Clyra Medical Technologies, Inc., focuses on advanced wound care management and is preparing to make FDA 510(k) applications in 2015.

Safe Harbor Statement

The statements contained herein, which are not historical, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, the risks and uncertainties included in BioLargo's current and future filings with the Securities and Exchange Commission, including those set forth in BioLargo's Annual Report on Form 10-K for the year ended December 31, 2013.

Contact Information

  • Company contact:
    Dennis Calvert
    BioLargo, Inc.
    949-643-9540 x1